Galectin Therapeutics, Inc. (GALT)
4.05
-0.09
(-2.17%)
USD |
NASDAQ |
Sep 09, 16:00
4.05
0.00 (0.00%)
After-Hours: 17:07
Galectin Therapeutics Total Liabilities (Quarterly) : 151.68M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 151.68M |
| March 31, 2026 | 146.00M |
| December 31, 2025 | 145.73M |
| September 30, 2025 | 136.44M |
| June 30, 2025 | 132.77M |
| March 31, 2025 | 121.79M |
| December 31, 2024 | 120.56M |
| September 30, 2024 | 121.45M |
| June 30, 2024 | 109.80M |
| March 31, 2024 | 96.98M |
| December 31, 2023 | 88.44M |
| September 30, 2023 | 73.04M |
| June 30, 2023 | 71.21M |
| March 31, 2023 | 62.87M |
| December 31, 2022 | 53.48M |
| September 30, 2022 | 40.25M |
| June 30, 2022 | 41.11M |
| March 31, 2022 | 39.81M |
| December 31, 2021 | 39.21M |
| September 30, 2021 | 28.79M |
| June 30, 2021 | 16.29M |
| March 31, 2021 | 4.663M |
| December 31, 2020 | 5.407M |
| September 30, 2020 | 2.507M |
| June 30, 2020 | 4.306M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.358M |
| December 31, 2019 | 2.872M |
| September 30, 2019 | 1.278M |
| June 30, 2019 | 1.391M |
| March 31, 2019 | 0.988M |
| December 31, 2018 | 2.108M |
| September 30, 2018 | 1.646M |
| June 30, 2018 | 1.435M |
| March 31, 2018 | 2.283M |
| December 31, 2017 | 2.968M |
| September 30, 2017 | 4.341M |
| June 30, 2017 | 3.512M |
| March 31, 2017 | 4.362M |
| December 31, 2016 | 3.78M |
| September 30, 2016 | 4.087M |
| June 30, 2016 | 3.636M |
| March 31, 2016 | 3.25M |
| December 31, 2015 | 1.36M |
| September 30, 2015 | 1.726M |
| June 30, 2015 | 1.908M |
| March 31, 2015 | 1.291M |
| December 31, 2014 | 1.703M |
| September 30, 2014 | 1.38M |
| June 30, 2014 | 2.147M |
| March 31, 2014 | 1.937M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.83M |
| Shareholders Equity (Quarterly) | -136.85M |
| Debt to Equity Ratio | -1.007 |
| Current Ratio | 0.0967 |
| Net Debt Paydown Yield | -1.94% |